All Type of News
Zantac Tab will be resupplied from this JulyA drug which has experienced the long-term out-of-stock crisis from the second half of the last year to this February due to the Tianjin explosion, Zantac is expected to be re-s...
|
Icure acquires approval of Phase 3 clinical trial of donepezil patches for the first time
Icure, a pharmaceutical R&D company owning the original technology of the Transdermal Drug Delivery System(TDDS) and having the largest market share in the donepezil market, acquired approval for the Phase 3 clinical ...
Government invests total 2.6 trillion in Bio & Health fields
On the 17th, the government confirmed and announced the ‘Investment Invigoration Measure’ at the 9th Trade and Investment Promotion Meeting hosted by the President.
The purpose of the measure was to promote private c...
Medical and pharmaceutical association complain of the MOHW’s health care services
When it came to the Ministry of Health and Welfare’s(MOHW) prompt announcement to push forward with health care services, medical and pharmaceutical associations have straightly expressed complaints. They indicated th...
Lantus and Tamiflu expired in patent on February
On February, Lantus and Tamiflu will expired in patent.
First of all, the Sanofi’s antidiabetic treatments, Lantus Inj Vial, Lantus Inj Solostar and Lantus Inj Cartridge, have been expired in their substance and use ...
Despite air shipment and full factory operation, Neodex is out-of-stock by March
The generic substitutes of Pfizer Pharmaceuticals Korea’s Terramycin Eye Oint have started to be out-of-stock again.
Despite the effort to increase their output by 5 times larger, the companies have only been able to...
Hanmi Pharm launches Korea’s first modified drug for influenza, ‘Hanmi Flu’Hanmi Pharm(CEO Kwan-soon Lee, www.hanmi.co.kr) announced to launch Hanmi Flu, the Korea’s first incrementally modified drug for influenza on the 16th.
The company stated Hanmi...
|
“Hae-cheol Shin Act is an rough-and-ready populism act”
As the so-called ‘Hae-cheol Shin Act,’ which automatically takes mediation processes without wills of people involved once medical disputes are received, is about to pass the National Assembly, medical associations ha...
Foreign directly-purchased drugs damage domestic pharmacies and pharmaceutical companies
The more overseas OTC drugs, the more side effects the domestic pharmaceutical market has gotten. If a popular product in other foreign countries is launched in Korea, in particular, the popularity has become more of ...
First ‘NOAC’ antidote, Praxbind, counting down for domestic introduction
The first NOAC antidote is expected to be introduced in Korea.
According to the industry concerned on the 17th, Boehringer Ingelheim recently turned in the approval application of ‘Praxbind(idaruxizumab),’ an antibod...
